TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making
- PMID: 32164894
- DOI: 10.1016/j.jacc.2019.12.057
TAVR in Low-Risk Patients: FDA Approval, the New NCD, and Shared Decision-Making
Keywords: Food and Drug Administration; heart team; national coverage determination; shared decision-making; transcatheter aortic valve replacement.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
